ConductScience.org, home

Library / Genes

SLC2A1: solute carrier family 2 member 1

1 protein, 83 patents, 0 drugs, 0 trials, 9,116 NIH grants and 23,998 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolSLC2A1HGNC
Namesolute carrier family 2 member 1HGNC
NCBI Gene ID6513NCBI Gene
HGNC IDHGNC:11005HGNC
EnsemblENSG00000117394NCBI Gene
AliasesCSE, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT-1, GLUT1, GLUT1DS, HTLVR, PED, SDCHCNNCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P11166Solute carrier family 2, facilitated glucose transporter member 14925Ensembl, GeneID, HGNCUniProt

Patents 83

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4827884 A12026-10-284P11166Espacenet
JP 2026123072 A2026-07-2926P11166Espacenet
WO 2026134194 A2026-06-251P11166Espacenet
JP 2026067851 A2026-04-21333P11166Espacenet
EP 4650780 A22025-11-1914002P11166Espacenet
EP 4641201 A22025-10-2916285P11166Espacenet
JP 2025147176 A2025-10-0616544P11166Espacenet
JP 2025529142 A2025-09-044134P11166Espacenet
US 12371689 B22025-07-294134P11166Espacenet
JP 2025517969 A2025-06-1216285P11166Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 9116

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant922,025NIH's project files
P30CA016672Cancer Center Support Grant712,025NIH's project files
ZIABC011038Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene292,025NIH's project files
ZIABC011028Clinical Studies of the Molecular Genetic Basis of Kidney Cancer282,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award262,025NIH's project files
P30DK036836Diabetes Research Center242,025NIH's project files
P30DK056341Washington University Nutrition Obesity Research Center242,025NIH's project files
P30CA046934University of Colorado Cancer Center Support Grant212,025NIH's project files
R01DK105550Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease212,025NIH's project files
P30CA076292Moffitt Cancer Center Support Grant202,025NIH's project files

Papers 23998

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42826094PubTator, text miningPubMed
42824025PubTator, text miningPubMed
42819982PubTator, text miningPubMed
42818363PubTator, text miningPubMed
42811626PubTator, text miningPubMed
42810159PubTator, text miningPubMed
42803887PubTator, text miningPubMed
42800514PubTator, text miningPubMed
42800208PubTator, text miningPubMed
42794529PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license